regeneron dna - Search News

Order byBest matchMost fresh

Regeneron Just Bought Your DNA From 23andMe

Digest more

DNA Giant 23andMe To Be Acquired After Bankruptcy

Genetic testing company 23andMe is being acquired, shortly after it declared bankruptcy months ago.

Hip-Hop Wired · 4m

· 1d · on MSN

Now we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.

· 1d · on MSN

Regeneron agrees to buy bankrupt 23andMe, promises ethical use of customers' DNA data

23andMe to Be Bought by Biotech Company for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

· 1d

23andMe Sold To Biotechnology Company For $256 Million

· 1d

Regeneron Pharmaceuticals to pay $256 million for 23andMe in bankruptcy sale

Biotechnology Company Regeneron to Buy 23andMe for $256 million

Privacy concerns related to customers’ genetic information have also emerged, notably spanning from a 2023 data breach — along with questions around what new ownership could mean for users’ data.

· 1d

Struggling DNA testing firm 23andMe to be bought for $256m

· 1d

23andMe and its user data will soon belong to a pharmaceutical giant

Lohud.com, Westchester County on MSN1d

Regeneron to acquire 23andMe DNA testing firm. How that could impact your genetic data

Regeneron announced a plan to acquire genetic testing firm 23andMe through bankruptcy court, including access to personal genetic data. What to know

MassDevice6h

Regeneron to acquire 23andMe for $256M, plans to continue consumer genetics services

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to close in Q3 2025

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.

Stocktwits on MSN1d

Regeneron To Buy Assets Of 23andMe For $256M: Retail Says ‘Fantastic’ For Future R&D Efforts

Drugmaker Regeneron Pharmaceuticals, Inc. (REGN) said on Monday that it will acquire the assets of bankrupt biotechnology company 23andMe Holding Co. for $256 million. Regeneron intends to acquire 23andMe’s Personal Genome Service (PGS),